The near-infrared imaging market size is expected to grow from an estimated USD 0.8 billion in 2021 to USD 1.6 billion by 2026, at a CAGR of 14.0%. The growing number of surgical procedures performed globally, advantages of NIR imaging over conventional visualization methods, and technological advancements in NIR imaging modalities. However, the lengthy approval process, which limits the availability of targeted fluorophores, is expected to restrain market growth to a certain extent during the forecast period.
The near-infrared imaging devices segment is expected account for the largest share of the near-infrared imaging market from 2021 to 2026. On the basis of product, devices and probe/dye.The devices product segment, by type, is further segmented into near-infrared fluorescence imaging systems and near-infrared fluorescence and bioluminescence imaging systems.
The near-infrared fluorescence imaging systems segment is estimated to account for the largest share of the near-infrared imaging market, by product, in 2021, driven by growing research activities, advantages offered by near-infrared fluorescence imaging systems such as high sensitivity, high image resolution, and real-time image guidance during surgeries, the rising prevalence of cancer, cardiovascular diseases, and gastrointestinal diseases.
The preclinical imaging segment is estimated to account for the largest share of the global near-infrared imaging application market from 2021 to 2026. On the basis of application, the near-infrared imaging market is segmented into preclinical imaging, clinical imaging, medical imaging. The preclinical imaging segment is estimated to account for the largest share of the global near-infrared imaging market, by application, in 2021, led by the The growing focus on developing new treatments for diseases/conditions such as cancer, inflammation, angiogenesis, infections, and vascular diseases.
The hospitals and clinics segment is expected to grow at the highest CAGR from 2021 to 2026. Based on end-user, the near-infrared imaging market has been segmented into hospitals & clinics, pharmaceutical and biotechnology companies, and research laboratories.As of 2020, hospitals & clinics are estimated to account for the largest share of the global near-infrared imaging market in 2021, and is also projected to register the highest CAGR during the forecast period.
The increasing clinical applications of NIR imaging in various therapeutic areas, the growing demand for NIR imaging among clinicians across the globe, and the high sensitivity, high resolution, and low cost of NIR imaging systems compared to conventional imaging systems such as CT and MRI are the major factors that are expected to drive the growth of this end-user segment in the coming years.
North America: The largest market in the near-infrared imaging industry.
North America accounted for the largest market share in the near-infrared imaging market in 2020. The near-infrared imaging market in North America is driven primarily by factors such as the high healthcare spending, rising geriatric population, the rising prevalence of target diseases, growing number of cosmetic surgeries, ongoing research activities, and rapid adoption of technologically advanced imaging systems.
Breakdown of Primaries: In-depth interviews have been conducted with various key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information, as well as to assess future market prospects. The distribution of primary interviews is as follows: • By Company Type: Tier 1- 48%, Tier 2- 36%, and Tier 3- 16% • By Designation: C-Level- 10%, Director Level- 14%, and Others- 76%
By Region: North America - 40%, Europe - 32%, Asia Pacific - 20%, Lain America - 5%, Middle East & Africa – 3% *Others include sales managers, engineers, and regional managers. Note: Tier 1 Company—Revenue > USD 5 billion, Tier 2 Company—Revenue between USD 1 and USD 5 billion, and Tier 3 Company—Revenue < USD 1 billion
The near-infrared imaging market is dominated by a few major players that have an extensive country presence such as Stryker (US), KARL STORZ SE & Co. KG (Germany), Carl Zeiss Meditec AG (Germany), Leica Microsystems (US), Olympus Corporation (Japan), and PerkinElmer, Inc. (US), among others.
Research Coverage: The report defines, describes, and forecasts the near-infrared imaging market, by product, application, procedure, end-user, and region.It also offers a detailed qualitative and quantitative analysis of the market.
The report provides a comprehensive review of the major market drivers, restraints, opportunities, and challenges. It also covers various important aspects of the market, which include the analysis of the competitive landscape, market dynamics, market estimates in terms of value, and future trends in the near-infrared imaging market.
Why Buy this Report? 1. The report identifies and addresses the key markets for the near-infrared imaging market, which would help equipment manufacturers and service providers review the growth in demand. 2. The report helps system providers understand the pulse of the market and provides insights into drivers, restraints, opportunities, and challenges. 3. The report will help key players understand the strategies of their competitors better and help them in making better strategic decisions.
Our reports have been used by over 10K customers, including:
The global revenue cycle management market is projected to reach USD 67.8 billion by 2026 from USD 40.9 billion in 2021, at a CAGR of 10.6% during the forecast period. The growth of this market is majorly attributed to the growing regulatory requirements & government initiatives to boost the adoption of RCM solutions, increasing patient volumes,...
344 pages •
By The Business Research Company
• Sep 2021
Anti-Asthmatics And COPD Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth provides the strategists, marketers and senior management with the critical information they need to assess the global anti-asthmatics and COPD drugs market as it emerges from the COVID 19 shut down. Description: Where...
The global Micropump market is expected to reach US$ 5,172.86 million in 2028 from as estimated value of US$ 1,553.01 million in 2021. The market is likely to grow with a CAGR of 18.8% from 2021-2028. The growth of the market is due to increasing demand for micropumps in medical device industry, and improved accuracy compared to traditional...
histopathology services market was valued at US$ 35,187.90 million by 2028 from US$ 23,890.44 million in 2021; it is expected to grow at a CAGR of 5.7% from 2021 to 2028. Factors such as rising demand for biologics and increasing prevalence of chronic diseases are driving the growth of the histopathology services market. However, limitations...
The N95 masks market is projected to reach US$ 4,925.80 million by 2028 from US$ 1,914.54 million in 2021; it is expected to grow at a CAGR of 14.5% from 2021 to 2028. Prevalence of COVID-19 and increasing investments and initiatives by market players, and governments drive the growth of the N95 masks market. However, the availability...
The ablation technology market is projected to reach USD 8.1 Billion by 2026 from USD 5.2 Billion in 2021, at a CAGR of 9.3% during the forecast period. The growing elderly population has also driven the incidence of target conditions and contributed to the demand for effective treatment. However, the reuse and reprocessing of devices in developed...
The global esoteric testing market is projected to reach USD 36.3 billion by 2026 from USD 21.0 billion in 2021, at a CAGR of 11.6% during the forecast period. Market growth is largely driven by the rising incidence of chronic and infectious diseases, increasing use of esoteric DNA sequencing technologies in precision medicine, early diagnosis...
The global infection surveillance solutions market is to reach USD 1,033 million by 2026 from USD 508 million in 2021, at a CAGR of 15.2%. The growth in this market can primarily be attributed to the increasing incidence of HAIs and increasing surgical procedures. The rising healthcare expenditure, an increasing number of surgeries, the growing...
The micro catheters and micro guidewires market in APAC is expected to grow from US$ 279.91 million in 2021 to US$ 422.26 million by 2028; it is estimated to grow at a CAGR of 6.0% from 2021 to 2028. Rising demand for minimally invasive procedures is also bolstering the growth of the industry.A minimally invasive medical procedure is...
The global amniotic products market is projected to reach USD 1.0 billion by 2026 from USD 0.7 billion in 2021, at a CAGR of 8.2% during the forecast period. The growth in this market can be attributed to the growth in the target patient population, rising incidence of burn injuries, awareness programs for wound care treatment and management,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.